Conference abstract · 29 Sep 2014
Review articlePublished 2016
Epigenetics and Immunotherapy: New Perspective for Breaking Chronic Viral Infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic or persistent viral infections, like HBV, HCV and HIV, are still a challenge for human health. More importantly, most human chronic viral infection will result in cancer, the top leading cause of death. So far antiviral drugs and immunotherapy have limited therapeutic effects on patients. New potential mechanisms of chronic viral infections are needed to explore before new effective therapeutic strategies can be put into use. Epigenetic alterations are an important hallmark of cancer. Recent studies indicate that chronic viral infections also induce epigenetic changes in the host. This review will try to summarize some of the most recent studies in these fields and explore a new strategy to break chronic viral infection by combining epigenetic therapy and immunotherapy.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 18 Sep 2023
Differential Expression Analysis of Natural Killer (NK) Cell Receptor (NKG2D) in Hepatitis C Virus-Infected Chronic Hepatitis and Hepatocellular Patients for the Development of Targeted Immunotherapy
Short communication · 13 May 2026
The Role of Immune Signaling Networks in Chronic Viral Infections and Persistent Host Responses
Perspective · 11 Mar 2026
Cellular Immune Regulation During Chronic Viral Infection: Clinical Considerations for Persistent Host Responses
Case series · 2018
Achieving Sustained Viral Remission in Patients with Chronic HCV Infection and Cryoglobulinemic Vasculitis Does Not Always Correlate with Normalization of the Serologic Markers
More from this journal
The newest in Immunotherapy: Open Access.
Perspective · 19 Mar 2025
Understanding the Immune Response to Checkpoint Inhibitors in Immunotherapy
Perspective · 19 Mar 2025
Advancing Immunotherapy: Future Directions in the Fight against Renal Cell Carcinoma
Short communication · 19 Mar 2025
Emerging Therapies: The Latest Developments in Autoimmune Disease Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalImmunotherapy: Open Access
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Jiabin Yan”

